Rdl Financial Lowered By $369,225 Its Reliance Steel & Aluminum Co (RS) Stake; Endurant Capital Management LP Cut By $363,800 Its Halozyme Therapeutics (HALO) Stake

February 15, 2018 - By Linda Rogers

Endurant Capital Management Lp decreased Halozyme Therapeutics Inc (HALO) stake by 15.63% reported in 2017Q3 SEC filing. Endurant Capital Management Lp sold 21,400 shares as Halozyme Therapeutics Inc (HALO)’s stock rose 2.38%. The Endurant Capital Management Lp holds 115,500 shares with $2.01 million value, down from 136,900 last quarter. Halozyme Therapeutics Inc now has $2.60B valuation. The stock increased 3.20% or $0.57 during the last trading session, reaching $18.41. About 694,279 shares traded. Halozyme Therapeutics, Inc. (NASDAQ:HALO) has risen 44.89% since February 15, 2017 and is uptrending. It has outperformed by 28.19% the S&P500.

Rdl Financial Inc decreased Reliance Steel & Aluminum Co (RS) stake by 25.85% reported in 2017Q3 SEC filing. Rdl Financial Inc sold 4,923 shares as Reliance Steel & Aluminum Co (RS)’s stock declined 16.82%. The Rdl Financial Inc holds 14,123 shares with $1.06 million value, down from 19,046 last quarter. Reliance Steel & Aluminum Co now has $6.46 billion valuation. The stock increased 2.65% or $2.29 during the last trading session, reaching $88.59. About 448,372 shares traded or 5.83% up from the average. Reliance Steel & Aluminum Co. (NYSE:RS) has risen 0.13% since February 15, 2017 and is uptrending. It has underperformed by 16.57% the S&P500.

Investors sentiment decreased to 1.26 in Q3 2017. Its down 0.76, from 2.02 in 2017Q2. It fall, as 14 investors sold HALO shares while 44 reduced holdings. 18 funds opened positions while 55 raised stakes. 118.53 million shares or 0.58% less from 119.22 million shares in 2017Q2 were reported. Secor Advsrs Lp reported 109,093 shares or 0.18% of all its holdings. Creative Planning accumulated 89,092 shares. Fmr stated it has 4.97 million shares. Meeder Asset Mngmt reported 0% of its portfolio in Halozyme Therapeutics, Inc. (NASDAQ:HALO). Adage Cap Partners Grp Limited Liability Company owns 0.01% invested in Halozyme Therapeutics, Inc. (NASDAQ:HALO) for 250,000 shares. Financial Bank Of Mellon Corp has invested 0.01% in Halozyme Therapeutics, Inc. (NASDAQ:HALO). Moreover, Dekabank Deutsche Girozentrale has 0.01% invested in Halozyme Therapeutics, Inc. (NASDAQ:HALO) for 66,500 shares. Aperio has invested 0% of its portfolio in Halozyme Therapeutics, Inc. (NASDAQ:HALO). Fred Alger Mngmt has invested 0.03% in Halozyme Therapeutics, Inc. (NASDAQ:HALO). Nj State Employees Deferred Compensation Plan accumulated 0.16% or 50,000 shares. Commonwealth Equity Svcs Inc accumulated 63,846 shares. Sg Americas Securities Ltd Liability Corp owns 0% invested in Halozyme Therapeutics, Inc. (NASDAQ:HALO) for 28,081 shares. Moreover, State Street Corporation has 0.01% invested in Halozyme Therapeutics, Inc. (NASDAQ:HALO) for 3.68M shares. Prudential Fincl invested in 12,676 shares or 0% of the stock. D E Shaw & Communications Inc reported 0.01% stake.

Among 9 analysts covering Halozyme Therapeutics (NASDAQ:HALO), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Halozyme Therapeutics had 21 analyst reports since August 11, 2015 according to SRatingsIntel. On Friday, January 6 the stock rating was downgraded by Citigroup to “Neutral”. Canaccord Genuity maintained Halozyme Therapeutics, Inc. (NASDAQ:HALO) on Wednesday, July 26 with “Buy” rating. The rating was maintained by Piper Jaffray on Wednesday, August 9 with “Buy”. As per Wednesday, November 8, the company rating was maintained by Canaccord Genuity. The rating was initiated by Wells Fargo with “Outperform” on Friday, December 4. Piper Jaffray maintained it with “Overweight” rating and $18 target in Friday, September 16 report. Barclays Capital maintained Halozyme Therapeutics, Inc. (NASDAQ:HALO) rating on Wednesday, February 24. Barclays Capital has “Overweight” rating and $16 target. On Tuesday, August 11 the stock rating was maintained by JMP Securities with “Market Outperform”. BMO Capital Markets maintained it with “Market Perform” rating and $15 target in Friday, September 15 report. As per Wednesday, January 24, the company rating was maintained by Deutsche Bank.

Endurant Capital Management Lp increased Biogen Inc (NASDAQ:BIIB) stake by 8,185 shares to 39,817 valued at $12.47M in 2017Q3. It also upped Allergan Plc stake by 6,950 shares and now owns 40,477 shares. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) was raised too.

Analysts await Halozyme Therapeutics, Inc. (NASDAQ:HALO) to report earnings on February, 27. They expect $0.67 EPS, up 419.05% or $0.88 from last year’s $-0.21 per share. HALO’s profit will be $94.51M for 6.87 P/E if the $0.67 EPS becomes a reality. After $0.02 actual EPS reported by Halozyme Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 3,250.00% EPS growth.

Investors sentiment decreased to 0.96 in 2017 Q3. Its down 0.27, from 1.23 in 2017Q2. It dived, as 32 investors sold RS shares while 105 reduced holdings. 31 funds opened positions while 101 raised stakes. 59.07 million shares or 1.45% less from 59.94 million shares in 2017Q2 were reported. The France-based Natixis has invested 0.05% in Reliance Steel & Aluminum Co. (NYSE:RS). Janney Montgomery Scott Ltd Liability holds 0% or 5,217 shares in its portfolio. Parametric Port Associate Lc invested in 304,450 shares or 0.03% of the stock. Dalton Greiner Hartman Maher & accumulated 3,790 shares. Epoch Inc stated it has 0.08% of its portfolio in Reliance Steel & Aluminum Co. (NYSE:RS). Bluemountain Cap Llc owns 14,327 shares. Voya Management Ltd Liability Com invested in 0.01% or 48,646 shares. Alpha Windward Limited has invested 0.34% in Reliance Steel & Aluminum Co. (NYSE:RS). Mason Street Ltd Liability Corporation stated it has 0.07% in Reliance Steel & Aluminum Co. (NYSE:RS). Bnp Paribas Arbitrage owns 40,688 shares. Glenmede Trust Communications Na accumulated 2,201 shares or 0% of the stock. Ubs Asset Mngmt Americas owns 0% invested in Reliance Steel & Aluminum Co. (NYSE:RS) for 68,122 shares. Cooke And Bieler LP reported 425,885 shares. Ig Mngmt Limited invested in 40,000 shares. Burney Com holds 0.03% or 5,307 shares in its portfolio.

Among 9 analysts covering Reliance Steel (NYSE:RS), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Reliance Steel had 36 analyst reports since September 8, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Hold” on Wednesday, October 4. Bank of America downgraded the shares of RS in report on Friday, February 19 to “Neutral” rating. The company was upgraded on Tuesday, September 8 by Bank of America. KeyBanc Capital Markets maintained the stock with “Buy” rating in Wednesday, September 27 report. KeyBanc Capital Markets upgraded the stock to “Overweight” rating in Monday, January 9 report. The firm has “Buy” rating by KeyBanc Capital Markets given on Tuesday, December 5. The company was maintained on Friday, June 23 by Deutsche Bank. Jefferies downgraded Reliance Steel & Aluminum Co. (NYSE:RS) on Monday, March 21 to “Hold” rating. The stock has “Outperform” rating by Macquarie Research on Tuesday, March 14. The stock has “Buy” rating by Cowen & Co on Thursday, August 31.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: